Search
for
Sort by
Research 19
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- Poster Abstracts
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- Ketoconazole Shampoo: Effect of Long-Term Use in Androgenic Alopecia
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor β Gene Are Associated with Androgen Levels in Women1
- Clinical Aspects and Spectrum of Illness of TSS: Overview
- Niosomes as a propitious carrier for topical drug delivery
- Toxic shock syndrome: Recent developments in pathogenesis
- Profile of dermatological consultations in Brazil (2018)
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- Can social media encourage young Polish adults to visit a dermatologist? An original study
- 13. Wound Healing & Hair
- 4. Bullous/Mucous Membrane
- Cutaneous manifestations of systemic infection in children
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Viral-associated trichodysplasia spinulosa: a case with electron microscopic and molecular detection of the trichodysplasia spinulosa-associated human polyomavirus